With a $125 million series B financing round, Diagonal Therapeutics has made a vertical move to advance its first-in-class rare disease drug DIAG723. The Massachusetts-based biotech, which develops ...
DIAMOND is generally thought to be one of the most perfect crystals occurring naturally: its atomic structure was first investigated in the very early days of X-ray crystal analysis. It turned out ...